Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Edward Ehrenwald"'
Autor:
Charles W. Nutting, Andrew S. Kennedy, Steven C. Rose, Michael Cohn, Edward Ehrenwald, Samuel G. Putnam, Navesh K. Sharma, David Ball, Alain Drooz, Fred M. Moeslein, Douglas M. Coldwell, Samir Kanani, Steven J. Cohen, Sabine Schirm, Eric A. Wang, Michael Savin
Publikováno v:
Journal of gastrointestinal oncology. 8(1)
Background: Patients with liver metastatic colorectal cancer (mCRC) often benefit from receiving 90 Y-microsphere radioembolization (RE) administered via the hepatic arteries. Prior to delivery of liver-directed radiation, standard laboratory tests m
Autor:
Charles W. Nutting, Andrew S. Kennedy, Samir Kanani, Steven C. Rose, Sabine Schirm, Steven J. Cohen, Michael Cohn, Navesh K. Sharma, Samuel G. Putnam, Edward Ehrenwald, Michael Savin, David Ball, Alain Drooz, Fred M. Moeslein, Eric W. Wang, Douglas M. Coldwell
Publikováno v:
Journal of Clinical Oncology. 32:292-292
292 Background: Patients with liver metastases from colorectal cancers (mCRC) can benefit from 90Y resin microsphere radioembolization (RE) administered via the hepatic arteries. This study investigated which standard laboratory tests may assist in i
Autor:
Michael Cohn, Samuel G. Putnam, Steven C. Rose, David Ball, Andrew S. Kennedy, Samir Kanani, Sabine Schirm, Charles W. Nutting, Alain Drooz, Fred M. Moeslein, Eric W. Wang, Edward Ehrenwald, Douglas M. Coldwell, Navesh K. Sharma, Steven J. Cohen, Michael Savin
Publikováno v:
Journal of Clinical Oncology. 31:e14545-e14545
e14545 Background: The effects of advanced age on the clinical outcomes following 90Y treatment in elderly patients with mCRC are relatively unknown. Methods: A retrospective review was conducted to evaluate clinical outcomes among 160 elderly (≥70
Autor:
Samir Kanani, Andrew S. Kennedy, Steven C. Rose, Edward Ehrenwald, Navesh K. Sharma, Fred M. Moeslein, Eric W. Wang, Charles W. Nutting, Michael Savin, Steven J. Cohen, David Ball, Alain Drooz, Samuel G. Putnam, Sabine Schirm, Douglas M. Coldwell, Michael Cohn
Publikováno v:
Journal of Clinical Oncology. 31:264-264
264 Background: 90Y-microspheres (radioembolization) are administered via the hepatic artery following failure of one or more lines of fluoropyrimidine-based systemic chemotherapy, with or without biologic agents in colorectal carcinoma metastatic (m
Autor:
Andrew S. Kennedy, Charles W. Nutting, Samuel G. Putnam, Fred M. Moeslein, Eric W. Wang, Michael Cohn, Navesh K. Sharma, Sabine Schirm, Alain Drooz, Steven C. Rose, Edward Ehrenwald, Michael Savin, Samir Kanani, Douglas M. Coldwell, David Ball, Steven J. Cohen
Publikováno v:
Journal of Clinical Oncology. 31:270-270
270 Background: Hepatic tumor progression after one or more lines of 5FU-based systemic chemotherapy, with or without biologic agents, is an indication for radioembolization using 90Y microspheres. Methods: An independent imaging review following res
Autor:
Douglas M. Coldwell, Samir Kanani, David Ball, Charles W. Nutting, Navesh K. Sharma, Andrew S. Kennedy, Michael Cohn, Steven C. Rose, Edward Ehrenwald, Fred M. Moeslein, Eric W. Wang, Alain Drooz, Sabine Schirm, Michael Savin, Steven J. Cohen
Publikováno v:
Journal of Clinical Oncology. 30:3590-3590
3590 Background: Implantation of radioactive microspheres via the hepatic artery with Yttrium-90 (90Y) is termed “radioembolization, (RE)”. Resin microspheres were FDA cleared for use in colorectal liver metastases (mCRC) in 2002. Rapid worldwide